Arthritis &Rheumatology, EarlyView.Objective Ear, nose, and throat (ENT) manifestations are common in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). There is an unmet need for drugs to target these manifestations. Granuloma formation is characteristic of proteinase 3 (PR3)–AAV. In a zebrafish model, niclosamide inhibits PR3‐induced granuloma formation.
Benjamin Lim +4 more
wiley +1 more source
Unraveling the mystery of placebo effect in research and practice: An update. [PDF]
Perspect Clin ResMishra P, Bhargava S.
europepmc +1 more source
Teaching neurons to respond to placebos
Journal of Physiology, 2016 F. Benedetti +7 more
semanticscholar +1 more source
The Placebo Effect in Medicine and Clinical Practice: A Narrative Review. [PDF]
CureusTzigkounakis G, Simati K, Georgiadis K.
europepmc +1 more source
Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6‐month, randomized, double‐blind study comparing finasteride plus tadalafil with finasteride plus placebo [PDF]
, 2015 Claus G. Roehrborn +5 more
openalex +1 more source
Arthritis &Rheumatology, EarlyView.Objective Our study objective was to identify serum protein signatures associated with progression to rheumatoid arthritis (RA) and response to abatacept in at‐risk individuals. Methods A total of 440 serum samples from 118 APIPPRA (Arthritis Prevention In the Preclinical Phase of RA with Abatacept) study participants were selected from baseline to RA ...
Marianna Jasenecova +9 more
wiley +1 more source
Effects of open-label placebos across populations and outcomes: an updated systematic review and meta-analysis of randomized controlled trials. [PDF]
Sci RepFendel JC +4 more
europepmc +1 more source
Double-blind placebo-controlled randomized clinical trial of verapamil for chronic rhinosinusitis with nasal polyps [PDF]
, 2017 Marcel M. Miyake +10 more
openalex +1 more source